Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Market Insights - Ofloxacin > Zhejiang Dongya Pharmaceutical's levofloxacin intermediates and APIs obtained Japanese GMP certification
— Share —

Zhejiang Dongya Pharmaceutical's levofloxacin intermediates and APIs obtained Japanese GMP certification

healthoo 2021-05-17
Zhejiang Dongya Pharmaceuticals announced that recently, the company and Jiangxi Shanyuan received the "Pharmaceutical Compliance Investigation Result Notice" issued by Japan PMDA

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.